about
Mesenchymal stem cells-based therapy as a potential treatment in neurodegenerative disorders: is the escape from senescence an answer?PACAP interacts with PAC1 receptors to induce tissue plasminogen activator (tPA) expression and activity in schwann cell-like culturesPACAP and VIP affect NF1 expression in rat malignant peripheral nerve sheath tumor (MPNST) cellsDopamine D3 receptor is necessary for ethanol consumption: an approach with buspironeAmeliorative effects of PACAP against cartilage degeneration. Morphological, immunohistochemical and biochemical evidence from in vivo and in vitro models of rat osteoarthritis.Emerging Role of PACAP as a New Potential Therapeutic Target in Major Diabetes Complications.Parkin expression profile in dopamine d3 receptor knock-out mice brains.Mucin 1 (MUC1) signalling contributes to increase the resistance to cell death in human bronchial epithelial cells exposed to nickel acetate.PACAP and VIP increase the expression of myelin-related proteins in rat schwannoma cells: involvement of PAC1/VPAC2 receptor-mediated activation of PI3K/Akt signaling pathways.Antiproliferative effects of PACAP and VIP in serum-starved glioma cells.Ameliorative effect of PACAP and VIP against increased permeability in a model of outer blood retinal barrier dysfunction.Epidermal growth factor receptor (EGFR) and neuregulin (Neu) activation in human airway epithelial cells exposed to nickel acetate.The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer's disease: agonists or antagonists?Angiogenesis correlates with macrophage and mast cell infiltration in lung tissue of animals exposed to fluoro-edenite fibers.Effects of PACAP and VIP on hyperglycemia-induced proliferation in murine microvascular endothelial cells.Dual blockade of the A1 and A2A adenosine receptor prevents amyloid beta toxicity in neuroblastoma cells exposed to aluminum chloride.Hippocampal neurofibromin and amyloid precursor protein expression in dopamine D3 receptor knock-out mice following passive avoidance conditioning.Dopamine D3 receptor deletion increases tissue plasminogen activator (tPA) activity in prefrontal cortex and hippocampus.Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam.Increased hippocampal CREB phosphorylation in dopamine D3 receptor knockout mice following passive avoidance conditioning.Tackling dipeptidyl peptidase IV in neurological disorders.Identification of Dysregulated microRNA Networks in Schwann Cell-Like Cultures Exposed to Immune Challenge: Potential Crosstalk with the Protective VIP/PACAP Neuropeptide System.Enhanced expression of CD31/platelet endothelial cell adhesion molecule 1 (PECAM1) correlates with hypoxia inducible factor-1 alpha (HIF-1α) in human glioblastoma multiforme.Degenerative disc disease of herniated intervertebral discs is associated with extracellular matrix remodeling, vimentin-positive cells and cell death.Involvement of PACAP/ADNP signaling in the resistance to cell death in malignant peripheral nerve sheath tumor (MPNST) cells.Dopamine-₃ receptor modulates intraocular pressure: implications for glaucoma.A correlation between intestinal microbiota dysbiosis and osteoarthritisModerate Physical Activity as a Prevention Method for Knee Osteoarthritis and the Role of Synoviocytes as Biological KeyNeurofibromin and amyloid precursor protein expression in dopamine D3 receptor knock-out mice brainsEarly changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic ratsDavunetide (NAP) protects the retina against early diabetic injury by reducing apoptotic deathPACAP and VIP expression in the periaqueductal grey of the rat following sciatic nerve constriction injuryDopaminergic-GABAergic interplay and alcohol binge drinkingEvaluation of a Cell-Free Collagen Type I-Based Scaffold for Articular Cartilage Regeneration in an Orthotopic Rat Model
P50
Q26801122-D1329A89-F21F-4726-AAF6-FFD2E29AEB5FQ28543252-B4E39708-3DC9-47DE-B69D-0CF156207A53Q28565364-47E804F7-F347-4935-9878-031096B2BC73Q33764334-A667051C-1099-4FB4-8223-328F28A30ED3Q35381453-C4273F6E-9BF9-4432-A0C5-CB355EF8E879Q35657065-2A18CF84-F41B-46BE-B422-F2FC0304FD0DQ38289431-2C345E3F-E1E0-4104-A000-A2B4CB79AB98Q38972631-13BA01E2-DEA0-4FE6-B5F8-1008ED5F3A29Q39061821-5326740A-7614-4104-ABD9-580AC7F08CAFQ39117664-E0503699-BFF5-4C31-8D76-B554F5BAB08CQ39230886-EACE7CDE-B2D5-4F99-8BF8-9BED69AA1A80Q39419287-BC91A91A-7673-4381-AF31-B6E38A34062AQ39490943-556F4887-E3B0-4039-92A5-C965CA016469Q39651397-DA1AEE7B-5635-43FF-BA87-8341DCB2B9ECQ39662394-CE811EA1-B5E0-418E-9BD5-45C3E3DFE8FFQ45831973-50C9A8F4-9F37-4AD7-8339-FDF1D9C7AADEQ45899153-1D68880B-774D-4224-9357-C565B7CAA2BDQ45904727-C56D618B-ED00-4451-A880-7AFB6390B4CFQ47775824-F2F6C20E-DBFB-42CB-B26F-FDF0F0B5B082Q48953071-F8D63102-ADFA-4968-8B27-6A66B652186FQ49940117-CA8B82FD-E467-4428-8AB8-64795AE2E81BQ51731153-441401B4-C863-456B-88E0-D97E321FBD29Q52149191-621C288F-2613-48EE-BA43-A6E8FD9456A2Q52608169-4588BD1A-78AF-4342-A874-B6B7FB094BB7Q54317199-ACF22B86-FC0A-45F8-9CD2-C3E9487CA0A2Q54333553-852BC3EC-A98F-4D05-AAAD-04A5FFC79D9BQ60910257-3577F61E-23A6-4DE0-9D64-E32057878A13Q64276516-E4887BB4-FFE6-47BA-91E5-9E13173A38EFQ82954939-996CA650-545C-4405-9A32-279855FD124FQ84431628-36C5D998-143D-42AF-989F-7E2B8635FF40Q87217412-E759CF05-44C0-4455-90CE-4E1AC9C39E44Q90719192-168EEF0C-3058-4C61-8B66-2B42EFC091E1Q91069174-2EC71F70-EB2C-4B95-9BCB-78C63791667DQ95827302-F63A4BD5-1D68-49D0-97A3-B40A1F6FADCA
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alessandro Castorina
@ast
Alessandro Castorina
@en
Alessandro Castorina
@es
Alessandro Castorina
@nl
type
label
Alessandro Castorina
@ast
Alessandro Castorina
@en
Alessandro Castorina
@es
Alessandro Castorina
@nl
prefLabel
Alessandro Castorina
@ast
Alessandro Castorina
@en
Alessandro Castorina
@es
Alessandro Castorina
@nl
P106
P1153
35274530300
P21
P2798
P31
P496
0000-0001-7037-759X